Study of the Efficacy of Maintenance Therapy Using UFT or BCG for the Prevention of Recurrences of Superficial Bladder Cancer Conducted by the Urological Oncology Council of Northern Tokyo.

Trial Profile

Study of the Efficacy of Maintenance Therapy Using UFT or BCG for the Prevention of Recurrences of Superficial Bladder Cancer Conducted by the Urological Oncology Council of Northern Tokyo.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 14 Oct 2010

At a glance

  • Drugs Tegafur/uracil (Primary) ; BCG
  • Indications Bladder cancer
  • Focus Therapeutic Use
  • Acronyms EMBARK
  • Most Recent Events

    • 12 Mar 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top